---
figid: PMC4759477__JCMM-20-389-g003
figlink: /pmc/articles/PMC4759477/figure/jcmm12749-fig-0003/
number: Figure 3
caption: A schematic representation of platycodin D‐induced G2/M phase cell cycle
  arrest in cancer cells. Platycodin D inhibits G2‐M phase transition by increasing
  the expression of transcription factor FOXO3a, p53, p21 and Weel, and decreasing
  the expression of MDM2 and induces M phase arrest by sustainable tubulin polymerization.
  Binding of ligand such as growth factor (EGF) to the growth factor receptor (EGFR)
  promotes the activation of downstream pro‐survival signalling pathways such as PI3K/AKT
  and MAPK/ERK pathways. Activated AKT and ERK translocate to the nucleus and inhibit
  the transcription of apoptosis promoting (Bim, FasL, TRAIL) and cell cycle regulatory
  genes (p21, p27) by phosphorylating FOXO3a and exporting it out of nucleus. ERK
  regulates the expression of MDM2 that ubiquitinates FOXO3a in response to ERK pathway
  activation leading to proteasomal degradation. Platycodin D induces G2/M phase arrest
  and apoptosis by increasing the expression of FOXO3a in nucleus by inhibiting AKT
  and ERK.
pmcid: PMC4759477
papertitle: Killing cancer with platycodin D through multiple mechanisms.
reftext: Muhammad Khan, et al. J Cell Mol Med. 2016 Mar;20(3):389-402.
pmc_ranked_result_index: '788'
pathway_score: 0.9709584
filename: JCMM-20-389-g003.jpg
figtitle: Platycodin D‐induced G2/M phase cell cycle arrest in cancer cells
year: '2016'
organisms: Homo sapiens
ndex: 83d0d20e-dec7-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4759477__JCMM-20-389-g003.html
  '@type': Dataset
  description: A schematic representation of platycodin D‐induced G2/M phase cell
    cycle arrest in cancer cells. Platycodin D inhibits G2‐M phase transition by increasing
    the expression of transcription factor FOXO3a, p53, p21 and Weel, and decreasing
    the expression of MDM2 and induces M phase arrest by sustainable tubulin polymerization.
    Binding of ligand such as growth factor (EGF) to the growth factor receptor (EGFR)
    promotes the activation of downstream pro‐survival signalling pathways such as
    PI3K/AKT and MAPK/ERK pathways. Activated AKT and ERK translocate to the nucleus
    and inhibit the transcription of apoptosis promoting (Bim, FasL, TRAIL) and cell
    cycle regulatory genes (p21, p27) by phosphorylating FOXO3a and exporting it out
    of nucleus. ERK regulates the expression of MDM2 that ubiquitinates FOXO3a in
    response to ERK pathway activation leading to proteasomal degradation. Platycodin
    D induces G2/M phase arrest and apoptosis by increasing the expression of FOXO3a
    in nucleus by inhibiting AKT and ERK.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CA
  - MDM2
  - BCL2L11
  - CDK1
  - PIK3R5
  - AKT3
  - PIK3CB
  - FASLG
  - PIK3CG
  - FOXO3
  - PIK3R3
  - PIK3CD
  - PIK3R6
  - NRAS
  - PIK3R4
  - AKT1
  - AKT2
  - TP53
  - HRAS
  - MAP2K1
  - MEA1
  - MAP2K2
  - KRAS
  - Cancer
  - Lung cancer
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: MDM2
  symbol: MDM2
  source: hgnc_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
- word: Bim
  symbol: BIM
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L11
  entrez: '10018'
- word: CDK1
  symbol: CDK1
  source: hgnc_symbol
  hgnc_symbol: CDK1
  entrez: '983'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Fasl
  symbol: FasL
  source: hgnc_alias_symbol
  hgnc_symbol: FASLG
  entrez: '356'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: FOXO3A
  symbol: FOXO3A
  source: hgnc_prev_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: Mea
  symbol: MEA
  source: hgnc_prev_symbol
  hgnc_symbol: MEA1
  entrez: '4201'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
---
